Week In Review: China To Set Time Limit On Drug Approval Process
August 23, 2015 at 11:58 AM EDT
Burning Rock Biotech, a Guangzhou oncology diagnostics company, completed a $23 million Series A+ round of funding. The company is developing diagnostic tests for solid tumor cancers that indicate the best treatment option for each patient.